Cervical Health Awareness Month | National Quality Measures Clearinghouse 1

Search | National Quality Measures Clearinghouse

Health Awareness Topics: January 2018

• Cervical Health Awareness Month (see related measures)

• MEASURE SUMMARY
 
• NQMC:010915
 
• 2016 MAY

Cervical cancer screening: percentage of women with a cytological finding of ASC-H/HSIL+ who had a histologic investigation within 12 months of the ASC-H/HSIL+ cytological finding.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:011175
 
• 2016 AUG

Cervical cancer: proportion of patients with cervical cancer who have an MRI of the pelvis performed prior to definitive treatment.

NHS Scotland; Scottish Cancer Taskforce

Compare

• MEASURE SUMMARY
 
• NQMC:010918
 
• 2016 MAY

Cervical cancer screening: percentage of Pap tests with an HSIL+ result that have a histological confirmation of HSIL, carcinoma in situ, or invasive carcinoma within 12 months of the HSIL+ Pap test.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:010927
 
• 2016 MAY

Cervical cancer screening: percentage of women with invasive cervical cancer—non-squamous cell carcinomas who are diagnosed within greater than 3 to 5 years since previous Pap test.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:011178
 
• 2016 AUG

Cervical cancer: proportion of patients with FIGO stage IB1 cervical cancer who undergo radical hysterectomy.

NHS Scotland; Scottish Cancer Taskforce

Compare

• MEASURE SUMMARY
 
• NQMC:010921
 
• 2016 MAY

Cervical cancer screening: age standardized incidence rate per 100,000 women of invasive cervical cancer—non-squamous cell carcinoma diagnosed in a year.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:010924
 
• 2016 MAY

Cervical cancer screening: percentage of women with invasive cervical cancer—squamous cell carcinoma who are diagnosed within greater than 3 to 5 years since previous Pap test.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:011181
 
• 2016 AUG

Cervical cancer: proportion of patients with cervical cancer undergoing radical radiotherapy who receive concurrent chemotherapy.

NHS Scotland; Scottish Cancer Taskforce

Compare

• MEASURE SUMMARY
 
• NQMC:010907
 
• 2016 MAY

Cervical cancer screening: percentage of eligible women who have a subsequent Pap test within 3 years (36 months) of the index test with a negative result.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:010913
 
• 2016 MAY

Cervical cancer screening: percentage of women with a high-grade Pap test result who had a follow-up colposcopy within 6 weeks of the index Pap test report date.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:009974
 
• 2014 SEP

Preventive services for adults: percentage of women ages 21 to 64 years who have screening for cervical cancer (Pap test) every three years.

Institute for Clinical Systems Improvement

Compare

• MEASURE SUMMARY
 
• NQMC:010009
 
• 2014 OCT

Cervical cancer screening: percentage of women age 21 years and older screened in accordance with evidence-based standards.

HealthPartners

Compare

• MEASURE SUMMARY
 
• NQMC:010910
 
• 2016 MAY

Cervical cancer screening: percentage of women with a negative ASCUS, LSIL, AGC, ASC-H, HSIL or more severe Pap test result.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:011176
 
• 2016 AUG

Cervical cancer: proportion of patients with cervical cancer undergoing primary radical radiotherapy who have PET/CT imaging prior to starting treatment.

NHS Scotland; Scottish Cancer Taskforce

Compare

• MEASURE SUMMARY
 
• NQMC:010919
 
• 2016 MAY

Cervical cancer screening: percentage of women with histology of HSIL per 1000 women who had a Pap test in the previous 12 months.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:009980
 
• 2014 SEP

Preventive services for adults: percentage of adolescent girls and women age 21 and younger who undergo cervical cancer screening.

Institute for Clinical Systems Improvement

Compare

• MEASURE SUMMARY
 
• NQMC:010916
 
• 2016 MAY

Cervical cancer screening: percentage of women who had a colposcopy within 12 months of a Pap test with an ASC-H/HSIL+ result who had a histologic investigation within 12 months of the ASC-H/HSIL+ cytological finding.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:010922
 
• 2016 MAY

Cervical cancer screening: percentage of invasive carcinoma of the cervix diagnosed at stage 1 in a 12-month period.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:010925
 
• 2016 MAY

Cervical cancer screening: percentage of women with invasive cervical cancer—squamous cell carcinoma who are diagnosed greater than 5 years since previous Pap test.

Canadian Partnership Against Cancer; Public Health Agency of Canada

Compare

• MEASURE SUMMARY
 
• NQMC:010932
 
• 2016 OCT

Non-recommended cervical cancer screening in adolescent females: percentage of adolescent females 16 to 20 years of age who were screened unnecessarily for cervical cancer.

National Committee for Quality Assurance